Last reviewed · How we verify

VGR-R01 — Competitive Intelligence Brief

VGR-R01 (VGR-R01) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ACE inhibitor. Area: Cardiovascular.

phase 3 ACE inhibitor ACE Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

VGR-R01 (VGR-R01) — Shanghai Vitalgen BioPharma Co., Ltd.. VGR-R01 is a small molecule drug that targets the renin-angiotensin system.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
VGR-R01 TARGET VGR-R01 Shanghai Vitalgen BioPharma Co., Ltd. phase 3 ACE inhibitor ACE
Ecclock SOFPIRONIUM BROMIDE Kaken Pharmaceutical marketed Muscarinic acetylcholine receptor M3 2024-01-01
Epkinly EPCORITAMAB Genmab Us, Inc. marketed Bispecific CD20-directed CD3 T Cell Engager [EPC] T-cell surface glycoprotein CD3 2023-01-01
Talvey TALQUETAMAB Janssen Biotech marketed T-cell surface glycoprotein CD3 2023-01-01
Tzield TEPLIZUMAB Provention Bio Inc marketed CD3-directed Antibody [EPC] T-cell surface glycoprotein CD3 2022-01-01
Candesartan Cilexetil CILEXETIL Alembic marketed Ace Inhibitor 2021-01-01
Mylotarg GEMTUZUMAB Wyeth Pharms Inc marketed CD33-directed Immunoconjugate [EPC] Myeloid cell surface antigen CD33 2020-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ACE inhibitor class)

  1. Boryung Pharmaceutical Co., Ltd · 5 drugs in this class
  2. Bioprojet · 2 drugs in this class
  3. Ain Shams University · 2 drugs in this class
  4. Ahn-Gook Pharmaceuticals Co.,Ltd · 1 drug in this class
  5. Beijing Tide Pharmaceutical Co., Ltd · 1 drug in this class
  6. Children's Hospital of Fudan University · 1 drug in this class
  7. Ache Laboratorios Farmaceuticos S.A. · 1 drug in this class
  8. Daewon Pharmaceutical Co., Ltd. · 1 drug in this class
  9. Ethicare GmbH · 1 drug in this class
  10. Ace Cells Lab Limited · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). VGR-R01 — Competitive Intelligence Brief. https://druglandscape.com/ci/vgr-r01. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: